Mehmet Ozgur Niflioglu, Mithat Bahceci, , Mithat BAHCECİ, Sakine Leyla ASLAN, James S. SHAWCROSS, Aliye Pelin TUTUNCUOGLU, Ece HARMAN

Diagnosis of diabetes mellitus and pre-diabetes with fasting plasma glucose, oral glucose tolerance test and A1C level: A1C based screening may be a better diagnostic tool for diabetes mellitus

OBJECTIVE: The International Diabetes Federation estimates that 285 million people around the world have diabetes. The American Diabetes Association (ADA) has proposed hemoglobin A1C 6.5% (HbA1c) for the diagnosis of diabetes, and 5.7-6.4% as a risk factor for progression to diabetes. This new criterions accuracy is controversial and has not yet been adopted internationally. We aimed to clarify the power of A1C in diagnosis of diabetes and pre-diabetes.

Keywords:

RESULTS: According to ADA criteria; 760 of 1814 individuals had diabetes mellitus (41.8 %). With each of these tests (HbA1c, 2-h OGTT and FPG), diabetes was detected in 529 (69.6%), 488 (64.2%) and 328 (43.2%) subjects respectively. Differences between, ,

PDF

___

Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. J Clin Invest. 1989;84:205-13.
American Diabetes Association. Diabetes Care. Diagnosis and Classification of Diabetes Mellitus. 2009; (32):S62-S67.
Uldry M, Thorens B. The sLC2 family of facilitated hexose and polyol transporters. Pflug Arch Eur J Phy. 2004;447: 480-9.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;1183-97.
The International Expert Committee. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care. 2009; 32(7):1327-34.
American Diabetes Association. Diabetes Care. Diagnosis and Classification of Diabetes Mellitus. 2010; (33):S62-S69.
Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, Bainbridge KE, Fradkin JE. Prevalence of diabetes and high risk for diabetes using hemoglobin A1C criteria in the U.S. population in 1988-2006. Diabetes Care. 2010;(33):562-8.
Kilpatrick ES, Bloomgarde ZT, Zimmet PZ. Is haemoglobin A1C a step forward for diagnosing diabetes? BRIT MED J. 2009;339:1288.
Mitchell D. Diabetes Experts Recommend A1C Testing for Diabetes Diagnosis "Switch Would Eliminate Need for Pretest Fasting" American Academy of Family Physicians News.2009. Http://www.aafp.org/online/en/home/publications/news/news- now/clinical-care-research/20090624A1C-diab-dx.html.
World Health Organization. Use of Glycated Haemoglobin (HbA1C) in the Diagnosis of Diabetes Mellitus Abbreviated Report of a WHO Consultation. 2011.
Colagiuri S, Cull CA, Holman RR, UKPDS Group. Are Lower Fasting Plasma Glucose Levels at Diagnosis of Type 2 Diabetes Associated With Improved Outcomes? Diabetes Care. 2011;25(8):1410-7.
Ceriello A, Ihnat MA, Thorpe JE. The "Metabolic Memory": Is More Than Just Tight Glucose Control Necessary to Prevent Diabetic Complications? J Clin Endocr Metab. 2009;94(2):410-5.
The ADVANCE Collaborative Group. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. New Engl J Med. 2008;358(24):2560-72.
The ADVANCE Collaborative Group. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. New Engl J Med. 2008;358(24):2545-59.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-53.
Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;9;359(15):1565-76.
Nathan DM, CP Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes. N Engl J Med. 2005;353(25):2643-53.